JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan International Research Enhanced Equity ETF
JIRE
|
+$4.16B |
| 2 |
Microsoft
MSFT
|
+$2.29B |
| 3 |
Amazon
AMZN
|
+$2B |
| 4 |
UnitedHealth
UNH
|
+$1.76B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.42B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$4.61B |
| 2 |
Vanguard Short-Term Bond ETF
BSV
|
+$1.58B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$689M |
| 4 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$659M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.03% |
| 2 | Healthcare | 12.52% |
| 3 | Financials | 10.5% |
| 4 | Consumer Discretionary | 7.88% |
| 5 | Industrials | 7.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1926
ScottsMiracle-Gro
SMG
$3.62B
| $11.9M | ﹤0.01% |
150,080
+51,109
| +52% | +$5.05M |
|
1927
NMI Holdings
NMIH
$3.38B
| $11.8M | ﹤0.01% |
711,371
+230,365
| +48% | +$4.19M |
|
1928
Huntsman Corp
HUN
$1.78B
| $11.8M | ﹤0.01% |
417,461
+105,166
| +34% | +$3.55M |
|
1929
iShares Core MSCI Total International Stock ETF
IXUS
$60.7B
| $11.8M | ﹤0.01% |
207,360
-11,246
| -5% | -$692K |
|
1930
Antero Resources
AR
$11.5B
| $11.8M | ﹤0.01% |
385,717
-1,504,074
| -80% | -$55M |
|
|
IAA
1931
PUT
DELISTED
IAA, Inc. Common Stock
IAA
| $11.8M | ﹤0.01% |
360,700
+332,700
| +1,188% | +$12.2M |
|
|
AZPN
1932
DELISTED
Aspen Technology Inc
AZPN
| $11.8M | ﹤0.01% |
+64,283
| New | +$11.4M |
|
1933
TORM
TRMD
$2.97B
| $11.8M | ﹤0.01% |
871,318
+859,691
| +7,394% | +$10.1M |
|
1934
CALL
Snap
SNAP
$8.79B
| $11.8M | ﹤0.01% |
897,900
-390,600
| -30% | -$8.91M |
|
1935
Avantor
AVTR
$9.42B
| $11.8M | ﹤0.01% |
378,944
+11,210
| +3% | +$350K |
|
1936
Grab
GRAB
$14.7B
| $11.8M | ﹤0.01% |
4,653,311
-935,017
| -17% | -$2.68M |
|
1937
CNO Financial Group
CNO
$5.02B
| $11.8M | ﹤0.01% |
650,702
-217,515
| -25% | -$4.65M |
|
1938
CALL
NextEra Energy
NEE
$179B
| $11.8M | ﹤0.01% |
151,900
+800
| +0.5% | +$60.9K |
|
1939
Hanover Insurance
THG
$7.74B
| $11.8M | ﹤0.01% |
80,440
-1,554
| -2% | -$228K |
|
|
TSVT
1940
DELISTED
2seventy bio
TSVT
| $11.8M | ﹤0.01% |
891,183
+408,376
| +85% | +$5.56M |
|
1941
Rocket Pharmaceuticals
RCKT
$374M
| $11.7M | ﹤0.01% |
851,594
+13,679
| +2% | +$163K |
|
|
NPTN
1942
DELISTED
NEOPHOTONICS CORP
NPTN
| $11.7M | ﹤0.01% |
744,968
+173,027
| +30% | +$2.64M |
|
1943
iShares Morningstar Growth ETF
ILCG
$3.28B
| $11.7M | ﹤0.01% |
233,713
-4,680
| -2% | -$259K |
|
1944
Vontier
VNT
$4.52B
| $11.7M | ﹤0.01% |
508,623
-58,716
| -10% | -$1.51M |
|
|
NEX
1945
DELISTED
NexTier Oilfield Solutions Inc.
NEX
| $11.7M | ﹤0.01% |
1,229,163
-173,020
| -12% | -$1.82M |
|
1946
BWX Technologies
BWXT
$15.8B
| $11.7M | ﹤0.01% |
212,081
+41,429
| +24% | +$2.15M |
|
1947
PUT
VanEck Durable High Dividend ETF
DURA
$39.2M
| $11.6M | ﹤0.01% |
50,000
| – | – |
|
1948
Donnelley Financial Solutions
DFIN
$1.17B
| $11.6M | ﹤0.01% |
396,753
-191
| -0% | -$5.67K |
|
1949
PUT
GE Aerospace
GE
$379B
| $11.6M | ﹤0.01% |
292,929
+111,714
| +62% | +$5.41M |
|
1950
CALL
Melco Resorts & Entertainment
MLCO
$2.14B
| $11.6M | ﹤0.01% |
2,013,300
+946,800
| +89% | +$5.55M |
|
Similar funds
JP Morgan Chase's Q2 2022 Portfolio in Review
As of Q2 2022, JP Morgan Chase held 7,270 positions worth $718B, down 14% from $830B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q2 2022 filing shows 568 new, 2,561 increased, 2,729 reduced and 610 closed positions. Its largest new stake was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B. The largest sale was JPMorgan BetaBuilders Europe ETF, an estimated $4.61B.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.
- JP Morgan Chase's largest Q2 2022 buy was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B.
- JP Morgan Chase added most to Microsoft in Q2 2022, an estimated $2.29B increase.
- JP Morgan Chase's biggest Q2 2022 reduction was JPMorgan BetaBuilders Europe ETF, cutting an estimated $4.61B.
- JP Morgan Chase fully exited Cerner Corp in Q2 2022, selling an estimated $608M.
- JP Morgan Chase's ten largest holdings make up 18% of its $718B portfolio in Q2 2022.
- JP Morgan Chase opened 568 new positions and closed 610 in Q2 2022.
- JP Morgan Chase's portfolio value fell 14% quarter-over-quarter to $718B.
Based on JP Morgan Chase's 13F filing for Q2 2022, filed 11 Aug 2022.